XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Premiums $ 76,897 $ 72,474 $ 154,885 $ 145,260
Investment and other income 997 1,115 2,008 1,913
Total revenues 98,855 92,903 198,651 184,834
Operating costs:        
Medical Costs 65,458 60,268 131,193 120,113
Operating costs 13,162 13,809 27,239 27,434
Cost of products sold 11,340 9,748 22,396 19,153
Depreciation and amortization 1,020 1,021 2,017 1,991
Total operating costs 90,980 84,846 182,845 168,691
Earnings from operations 7,875 8,057 15,806 16,143
Interest expense (985) (828) (1,829) (1,582)
Loss on sale of subsidiary and subsidiaries held for sale (1,225) 0 (8,311) 0
Earnings before income taxes 5,665 7,229 5,666 14,561
Provision for income taxes (1,244) (1,572) (2,466) (3,130)
Net earnings 4,421 5,657 3,200 11,431
Earnings attributable to noncontrolling interests (205) (183) (393) (346)
Net earnings attributable to UnitedHealth Group common shareholders $ 4,216 $ 5,474 $ 2,807 $ 11,085
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 4.58 $ 5.89 $ 3.05 $ 11.91
Diluted $ 4.54 $ 5.82 $ 3.02 $ 11.77
Basic weighted-average number of common shares outstanding 921 930 921 931
Dilutive effect of common share equivalents 7 10 8 11
Diluted weighted-average number of common shares outstanding 928 940 929 942
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 8 7 7 6
Products        
Revenues:        
Revenue from Products and Services $ 12,211 $ 10,651 $ 24,120 $ 20,918
Services        
Revenues:        
Revenue from Products and Services $ 8,750 $ 8,663 $ 17,638 $ 16,743